Home » Newsletters » BioWorld Science

BioWorld Science

April 9, 2010

View Archived Issues

CD34 marker suggests sunitinib targets tumor vasculature in clear cell renal cell carcinoma

Eosinophil cationic protein identified as new biomarker for coronary artery disease

New dipeptidyl peptidase 4 inhibitors discovered by Cadila Pharmaceuticals

New nonopioid analgesics claimed by Elder Pharmaceuticals

Arena Pharmaceuticals and Merck & Co. claim new GPR81 agonists

Preclinical pharmacology of Lexicon Pharmaceuticals' S1PL inhibitors described

Merck & Co. selects new lead NK1 antagonist for further evaluation

Leptin therapy proves advantageous in mouse model of type 1 diabetes

Merck & Co.'s new BB3 agonist reduces weight in obesity model

Achaogen discloses novel carbacephems

New mitochondrial F1F0 ATPase hydrolase inhibitors claimed by U.S. scientists

AnaptysBio collaborates with VLST to generate novel antibody therapeutics

Health Canada approves Seasonique contraceptive

Tioga receives SPA agreement from FDA for phase III asimadoline trials in D-IBS

Seattle Genetics, Takeda and Millennium begin phase III trial of brentuximab vedotin

Crucell and GSK collaborate to develop second-generation malaria vaccine

Inovio completes enrollment in phase I VGX-3100 cervical cancer vaccine trial

MAP Pharmaceuticals begins pharmacodynamics trial of Levadex migraine therapy

Swedish Orphan Biovitrum and LFB launch Willfact in Germany for von Willebrand's disease

Sanofi-aventis obtains exclusive worldwide license for new regenerative diabetes therapeutic

King Pharmaceuticals begins phase IIb Eladur trial in chronic low back pain

FDA to review Abbott's diagnostic test for acute kidney injury risk

Hemispherx Biopharma to study Alferon N Injection for hospitalized influenza patients

Calistoga begins phase I combination trial of CAL-101 in non-Hodgkin's lymphoma and leukemia

CytRx begins phase II bafetinib trial in advanced prostate cancer

Synairgen starts phase II trial of inhaled IFN-beta in asthma caused by respiratory viruses

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...